In the May 1, 2006 issue of Biological Psychiatry, Volume 59, Issue 9, in the abstract and also the Efficacy section of the article “A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder” by Biederman et al. (Biol Psychiatry 2006;59:829–835), it is reported that 39% (N = 23) of placebo subjects were responders. It should have been reported as 39% (N = 29).
Article info
Identification
Copyright
© 2007 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity DisorderBiological PsychiatryVol. 59Issue 9
